MTOR and Parkinson disease: In mouse models of Parkinson’s disease, treatment of L-DOPA activates mTOR complex one, which is involved in neural synaptic rehabilitation directed toward the basal ganglia, proving to be a promising therapeutic approach for future clinical trials of PD [97].